Amdocs (DOX) Stock Price
Amdocs Price
Amdocs (DOX) — ISIN GB0022569080. The Amdocs stock price was 68.58 USD in 2026. Revenue was 4.74 B USD. Earnings were 829.8 M USD. P/E ratio was 9.06. Amdocs operates in the Information technology sector.
Amdocs stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Amdocs over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Amdocs stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Amdocs's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Amdocs Price |
|---|---|
| 3/5/2026 | 68.58 USD |
| 2/27/2026 | 67.31 USD |
| 2/26/2026 | 69.84 USD |
| 2/25/2026 | 66.46 USD |
| 2/24/2026 | 67.26 USD |
| 2/23/2026 | 67.39 USD |
| 2/20/2026 | 70.18 USD |
| 2/19/2026 | 69.82 USD |
| 2/18/2026 | 70.56 USD |
| 2/17/2026 | 67.89 USD |
| 2/13/2026 | 69.24 USD |
| 2/12/2026 | 68.34 USD |
| 2/11/2026 | 69.84 USD |
| 2/10/2026 | 73.64 USD |
| 2/9/2026 | 73.28 USD |
| 2/6/2026 | 73.69 USD |
| 2/5/2026 | 71.66 USD |
| 2/4/2026 | 73.07 USD |
Amdocs Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Amdocs Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.12 | 0.17 | 0.21 | 0.29 | 0.4 | 0.63 | 1.12 | 1.53 | 1.61 | 1.48 | 1.77 | 2.04 | 2.48 | 2.84 | 3.16 | 2.86 | 2.98 | 3.18 | 3.25 | 3.35 | 3.56 | 3.64 | 3.72 | 3.87 | 3.97 | 4.09 | 4.17 | 4.29 | 4.58 | 4.89 | 5 | 4.53 | 4.74 | 4.91 | 5.18 | 5.34 | 5.55 | 5.78 |
| – | 28.72 | 38.02 | 26.35 | 37.44 | 38.97 | 55.33 | 78.59 | 37.12 | 5.22 | -8.06 | 19.55 | 14.95 | 21.69 | 14.35 | 11.50 | -9.49 | 4.26 | 6.47 | 2.17 | 3.05 | 6.52 | 2.25 | 2.06 | 4.01 | 2.77 | 2.82 | 2.03 | 2.85 | 6.72 | 6.80 | 2.39 | -9.43 | 4.48 | 3.72 | 5.48 | 2.99 | 3.97 | 4.13 |
| 46.81 | 44.63 | 41.92 | 36.97 | 38.62 | 39.95 | 42.01 | 42.22 | 44.36 | 42.16 | 38.44 | 36.66 | 36.46 | 36.13 | 36.64 | 35.90 | 35.92 | 36.13 | 34.88 | 35.77 | 35.22 | 35.25 | 35.52 | 35.23 | 35.14 | 34.70 | 35.07 | 33.89 | 34.44 | 35.38 | 35.34 | 35.07 | 37.97 | 36.35 | 35.04 | 33.22 | 32.26 | 31.03 | 29.80 |
| 0.04 | 0.05 | 0.07 | 0.08 | 0.11 | 0.16 | 0.26 | 0.47 | 0.68 | 0.68 | 0.57 | 0.65 | 0.74 | 0.9 | 1.04 | 1.14 | 1.03 | 1.08 | 1.11 | 1.16 | 1.18 | 1.26 | 1.29 | 1.31 | 1.36 | 1.38 | 1.43 | 1.41 | 1.48 | 1.62 | 1.73 | 1.76 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 |
| 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.03 | 0.1 | 0.01 | 0.07 | -0.01 | 0.17 | 0.23 | 0.29 | 0.32 | 0.36 | 0.38 | 0.33 | 0.34 | 0.35 | 0.39 | 0.41 | 0.42 | 0.44 | 0.41 | 0.43 | 0.35 | 0.48 | 0.49 | 0.68 | 0.54 | 0.53 | 0.48 | 0.55 | 0.83 | 0.9 | 0.97 | 1.08 | 1.18 | 0 |
| – | -15.79 | -31.25 | 118.18 | -79.17 | 500.00 | 226.67 | -93.88 | 1,000.00 | -107.58 | -3,460.00 | 39.29 | 23.08 | 10.42 | 14.47 | 3.85 | -13.76 | 5.21 | 0.87 | 13.01 | 5.37 | 2.43 | 4.50 | -8.16 | 6.91 | -18.94 | 35.61 | 3.78 | 37.85 | -20.56 | -1.85 | -9.04 | 14.70 | 49.64 | 8.32 | 8.02 | 11.75 | 8.49 | – |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.52 | 0.52 | 0.62 | 0.68 | 0.78 | 0.88 | 1.00 | 1.14 | 1.31 | 1.44 | 1.58 | 1.74 | 1.92 | 2.11 | 2.11 | 2.67 | 2.90 | - | - | - |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 19.23 | 9.68 | 14.71 | 12.82 | 13.64 | 14.00 | 14.91 | 9.92 | 9.72 | 10.13 | 10.34 | 9.90 | – | 26.54 | 8.61 | – | – | – |
| 92.2 | 92.2 | 100.3 | 110.5 | 110.9 | 159.4 | 200.3 | 216.9 | 226.8 | 220.4 | 219.9 | 220.3 | 217.2 | 218.5 | 223.3 | 220.3 | 208.4 | 204.1 | 186.6 | 169.4 | 163.1 | 161.4 | 155.2 | 149.9 | 146.3 | 142.6 | 137.2 | 133.2 | 127.97 | 121.89 | 118.49 | 113.96 | 109.66 | 109.66 | 109.66 | 109.66 | 109.66 | 109.66 | 109.66 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Amdocs generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Amdocs retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Amdocs's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Amdocs has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Amdocs's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROAmdocs Stock Quarterly Figures
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| 1997 Q1 | 1997 Q2 | 1997 Q3 | 1997 Q4 | 1998 Q1 | 1998 Q2 | 1998 Q3 | 1998 Q4 | 1999 Q1 | 1999 Q2 | 1999 Q3 | 1999 Q4 | 2000 Q1 | 2000 Q2 | 2000 Q3 | 2000 Q4 | 2001 Q1 | 2001 Q2 | 2001 Q3 | 2001 Q4 | 2002 Q1 | 2002 Q2 | 2002 Q3 | 2002 Q4 | 2003 Q1 | 2003 Q2 | 2003 Q3 | 2003 Q4 | 2004 Q1 | 2004 Q2 | 2004 Q3 | 2004 Q4 | 2005 Q1 | 2005 Q2 | 2005 Q3 | 2005 Q4 | 2006 Q1 | 2006 Q2 | 2006 Q3 | 2006 Q4 | 2007 Q1 | 2007 Q2 | 2007 Q3 | 2007 Q4 | 2008 Q1 | 2008 Q2 | 2008 Q3 | 2008 Q4 | 2009 Q1 | 2009 Q2 | 2009 Q3 | 2009 Q4 | 2010 Q1 | 2010 Q2 | 2010 Q3 | 2010 Q4 | 2011 Q1 | 2011 Q2 | 2011 Q3 | 2011 Q4 | 2012 Q1 | 2012 Q2 | 2012 Q3 | 2012 Q4 | 2013 Q1 | 2013 Q2 | 2013 Q3 | 2013 Q4 | 2014 Q1 | 2014 Q2 | 2014 Q3 | 2014 Q4 | 2015 Q1 | 2015 Q2 | 2015 Q3 | 2015 Q4 | 2016 Q1 | 2016 Q2 | 2016 Q3 | 2016 Q4 | 2017 Q1 | 2017 Q2 | 2017 Q3 | 2017 Q4 | 2018 Q1 | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1e | 2026 Q2e | 2026 Q3e | 2026 Q4e | 2027 Q1e | 2027 Q2e | 2027 Q3e | 2027 Q4e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.06 | 0.08 | 0.09 | 0.09 | 0.09 | 0.11 | 0.12 | 0.13 | 0.15 | 0.16 | 0.18 | 0.24 | 0.27 | 0.3 | 0.32 | 0.34 | 0.37 | 0.4 | 0.42 | 0.42 | 0.46 | 0.38 | 0.36 | 0.34 | 0.36 | 0.38 | 0.41 | 0.43 | 0.44 | 0.45 | 0.45 | 0.47 | 0.49 | 0.51 | 0.57 | 0.59 | 0.6 | 0.63 | 0.67 | 0.69 | 0.71 | 0.71 | 0.73 | 0.74 | 0.77 | 0.82 | 0.83 | 0.75 | 0.71 | 0.69 | 0.71 | 0.72 | 0.74 | 0.75 | 0.76 | 0.78 | 0.79 | 0.8 | 0.81 | 0.81 | 0.81 | 0.81 | 0.82 | 0.83 | 0.83 | 0.84 | 0.85 | 0.86 | 0.9 | 0.9 | 0.9 | 0.91 | 0.9 | 0.91 | 0.93 | 0.92 | 0.93 | 0.93 | 0.94 | 0.95 | 0.97 | 0.97 | 0.98 | 0.98 | 0.99 | 1 | 1 | 1.01 | 1.02 | 1.02 | 1.03 | 1.04 | 1.05 | 1.03 | 1.05 | 1.09 | 1.05 | 1.07 | 1.09 | 1.1 | 2.25 | 1.16 | 1.17 | 1.19 | 2.41 | 1.24 | 1.24 | 1.25 | 1.25 | 1.25 | 1.26 | 1.11 | 1.13 | 1.14 | 1.15 | 1.17 | 1.18 | 1.19 | 1.21 | 1.2 | 1.21 | 1.22 | 1.23 |
| – | – | 24.19 | 14.29 | -2.27 | 9.30 | 12.77 | 9.43 | 12.93 | 12.21 | 11.56 | 10.98 | 29.12 | 14.89 | 10.00 | 6.06 | 8.57 | 8.77 | 8.60 | 2.72 | 1.69 | 7.82 | -16.48 | -6.58 | -4.51 | 4.72 | 6.20 | 9.02 | 4.14 | 3.27 | 1.81 | 0.44 | 3.76 | 4.05 | 3.89 | 13.02 | 2.44 | 2.39 | 4.16 | 6.23 | 3.91 | 2.17 | 0.85 | 1.97 | 2.20 | 4.31 | 5.94 | 0.61 | -8.73 | -5.58 | -2.95 | 2.46 | 2.40 | 2.76 | 1.21 | 1.20 | 1.71 | 1.68 | 1.65 | 1.37 | -0.62 | 0.12 | – | 1.73 | 0.49 | 0.73 | 1.08 | 0.48 | 2.25 | 3.70 | 0.67 | -0.22 | 0.67 | -0.44 | 0.55 | 2.09 | -0.54 | 0.43 | 0.54 | 1.08 | 1.49 | 1.26 | – | 1.35 | -0.20 | 1.54 | 1.01 | – | 1.00 | 0.69 | 0.49 | 0.59 | 1.17 | 0.48 | -2.01 | 2.53 | 3.23 | -3.50 | 1.72 | 1.97 | 1.56 | 103.71 | -48.42 | 0.52 | 1.63 | 103.29 | -48.73 | 0.57 | 0.24 | – | 0.40 | 1.04 | -12.11 | 1.62 | 1.42 | 0.52 | 1.48 | 1.03 | 0.76 | 1.68 | -0.99 | 1.00 | 1.32 | 0.65 |
| 37.10 | 38.71 | 35.06 | 40.91 | 38.37 | 38.30 | 40.57 | 41.38 | 41.22 | 42.18 | 42.07 | 42.86 | 40.43 | 41.85 | 42.76 | 43.17 | 43.27 | 44.09 | 44.80 | 44.58 | 45.26 | 44.84 | 38.68 | 38.59 | 39.53 | 39.72 | 38.46 | 36.01 | 36.21 | 36.88 | 36.67 | 36.73 | 36.89 | 36.27 | 35.90 | 36.65 | 35.95 | 35.11 | 35.46 | 37.44 | 36.76 | 36.54 | 36.80 | 36.36 | 36.39 | 36.05 | 35.49 | 35.64 | 35.59 | 35.72 | 35.94 | 36.21 | 36.19 | 35.89 | 36.12 | 36.09 | 34.32 | 34.90 | 34.83 | 35.22 | 35.81 | 35.89 | 35.64 | 35.52 | 35.11 | 35.34 | 34.96 | 35.38 | 35.42 | 34.93 | 35.14 | 35.33 | 36.64 | 35.70 | 34.73 | 34.88 | 35.29 | 35.14 | 35.27 | 35.00 | 34.91 | 35.61 | 34.99 | 35.04 | 34.19 | 34.78 | 35.03 | 34.63 | 34.68 | 35.23 | 35.16 | 35.24 | 34.07 | 34.19 | 33.53 | 33.17 | 32.87 | 34.64 | 35.27 | 34.87 | 35.05 | 35.17 | 35.52 | 35.59 | 36.12 | 35.53 | 34.90 | 35.27 | 34.70 | 35.58 | 35.20 | 34.68 | 38.47 | 38.12 | 37.85 | 37.39 | 36.85 | 36.47 | 36.20 | 35.60 | 35.95 | 35.60 | 35.13 | 34.90 |
| 23 | 24 | 27 | 36 | 33 | 36 | 43 | 48 | 54 | 62 | 69 | 78 | 95 | 113 | 127 | 136 | 148 | 164 | 181 | 185 | 191 | 204 | 147 | 137 | 134 | 141 | 145 | 148 | 155 | 163 | 165 | 166 | 173 | 177 | 182 | 210 | 211 | 211 | 222 | 249 | 254 | 258 | 262 | 264 | 270 | 279 | 291 | 294 | 268 | 254 | 248 | 256 | 262 | 267 | 272 | 275 | 266 | 275 | 279 | 286 | 289 | 290 | 288 | 292 | 290 | 294 | 294 | 299 | 306 | 313 | 317 | 318 | 332 | 322 | 315 | 323 | 325 | 325 | 328 | 329 | 333 | 344 | 338 | 343 | 334 | 345 | 351 | 347 | 351 | 359 | 360 | 363 | 355 | 358 | 344 | 349 | 357 | 363 | 376 | 379 | 387 | 791 | 412 | 415 | 428 | 856 | 431 | 438 | 432 | 443 | 440 | 438 | 427 | 430 | 433 | 430 | 430 | 430 | 430 | 430 | 430 | 430 | 430 | 430 |
| 8 | 8 | 7 | -18 | 8 | 4 | 6 | 11 | 20 | 23 | 25 | 29 | 17 | 42 | -67 | 13 | 12 | 15 | 18 | 19 | 4 | 26 | -26 | -9 | 32 | 45 | 47 | 43 | 53 | 60 | 59 | 61 | 69 | 74 | 77 | 67 | 75 | 81 | 85 | 76 | 93 | 87 | 88 | 96 | 95 | 99 | 100 | 82 | 74 | 80 | 85 | 85 | 88 | 68 | 92 | 94 | 73 | 94 | 91 | 87 | 92 | 101 | 98 | 98 | 99 | 104 | 119 | 89 | 101 | 110 | 109 | 100 | 131 | 116 | 107 | 86 | 99 | 106 | 104 | 94 | 97 | 111 | 118 | 106 | 116 | 101 | 90 | 44 | 101 | 123 | 130 | 121 | 115 | 126 | 119 | 133 | 296 | 117 | 144 | 122 | 131 | 288 | 126 | 127 | 127 | 274 | 156 | 100 | 145 | 116 | 137 | 84 | 148 | 160 | 151 | 94 | 197 | 195 | 208 | 221 | 213 | 215 | 222 | 234 |
| – | – | -12.50 | -357.14 | -144.44 | -50.00 | 50.00 | 83.33 | 81.82 | 15.00 | 8.70 | 16.00 | -41.38 | 147.06 | -259.52 | -119.40 | -7.69 | 25.00 | 20.00 | 5.56 | -78.95 | 550.00 | -200.00 | -65.38 | -455.56 | 40.63 | 4.44 | -8.51 | 23.26 | 13.21 | -1.67 | 3.39 | 13.11 | 7.25 | 4.05 | -12.99 | 11.94 | 8.00 | 4.94 | -10.59 | 22.37 | -6.45 | 1.15 | 9.09 | -1.04 | 4.21 | 1.01 | -18.00 | -9.76 | 8.11 | 6.25 | – | 3.53 | -22.73 | 35.29 | 2.17 | -22.34 | 28.77 | -3.19 | -4.40 | 5.75 | 9.78 | -2.97 | – | 1.02 | 5.05 | 14.42 | -25.21 | 13.48 | 8.91 | -0.91 | -8.26 | 31.00 | -11.45 | -7.76 | -19.63 | 15.12 | 7.07 | -1.89 | -9.62 | 3.19 | 14.43 | 6.31 | -10.17 | 9.43 | -12.93 | -10.89 | -51.11 | 129.55 | 21.78 | 5.69 | -6.92 | -4.96 | 9.57 | -5.56 | 11.76 | 122.56 | -60.47 | 23.08 | -15.28 | 7.38 | 119.85 | -56.25 | 0.79 | – | 115.75 | -43.07 | -35.90 | 45.00 | -20.00 | 18.10 | -38.69 | 76.19 | 8.11 | -5.63 | -37.75 | 109.57 | -1.02 | 6.67 | 6.25 | -3.62 | 0.94 | 3.26 | 5.41 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.16 | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.20 | 0.20 | 0.20 | 0.20 | 0.22 | 0.22 | 0.22 | 0.22 | 0.25 | 0.25 | 0.25 | 0.25 | - | 0.29 | 0.29 | 0.29 | 0.33 | 0.33 | 0.33 | 0.33 | 0.36 | 0.36 | 0.36 | 0.36 | 0.40 | 0.40 | 0.40 | 0.40 | 0.44 | 0.44 | 0.44 | 0.44 | 0.48 | 0.48 | 0.48 | 0.48 | 0.53 | 0.53 | 0.53 | 0.53 | - | - | - | - | - | - | - |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15.38 | – | – | – | 13.33 | – | – | – | 17.65 | – | – | – | 10.00 | – | – | – | 13.64 | – | – | – | – | – | – | – | 17.86 | – | – | – | 9.09 | – | – | – | 11.11 | – | – | – | 7.50 | – | – | – | 11.63 | – | – | – | 10.42 | – | – | – | – | – | – | – | – | – | – |
| 110.5 | 110.5 | 110.5 | 107.9 | 127.3 | 129.7 | 182.7 | 198.4 | 198.9 | 199.5 | 200.3 | 201.9 | 204.9 | 211.4 | 220 | 227.2 | 226.4 | 227.2 | 226.9 | 225.7 | 225.1 | 225.5 | 220.2 | 215.6 | 217.1 | 219.1 | 220.8 | 221.6 | 220.6 | 216.2 | 222.2 | 208.2 | 217.4 | 218.8 | 216.6 | 215.8 | 214.9 | 217.9 | 220.1 | 221.2 | 222.7 | 222.5 | 223.8 | 224 | 222 | 219.8 | 219.1 | 217.5 | 213.1 | 210.6 | 204.3 | 205.4 | 206.7 | 207.7 | 205.5 | 196.5 | 193 | 189.2 | 184.7 | 179.4 | 173.8 | 171 | 168.3 | 164.7 | 163.6 | 162.9 | 162.7 | 163.3 | 161.8 | 162.3 | 161.7 | 159.6 | 158.1 | 157.4 | 156.6 | 148.8 | 150.8 | 150.6 | 149.5 | 147.8 | 147.2 | 146.8 | 146.1 | 145 | 143.6 | 143.3 | 142.1 | 140.8 | 139.6 | 137.7 | 136.1 | 135.2 | 134.7 | 134 | 132.6 | 131.6 | 129.6 | 129.3 | 126.65 | 125.41 | 122.43 | 123.63 | 123.15 | 115.26 | 119.37 | 118.65 | 118.25 | 116.79 | 115.04 | 114.91 | 113.33 | 112.17 | 111.36 | 110.4 | 109.1 | 107.77 | 107.77 | 107.77 | 107.77 | 107.77 | 107.77 | 107.77 | 107.77 | 107.77 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Amdocs generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Amdocs retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Amdocs's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Amdocs has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Amdocs's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROAmdocs stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Amdocs Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Amdocs business model
Amdocs SWOT Analysis
Strengths
1. Established market presence: Amdocs Ltd has built a strong reputation and prominent position in the telecommunications industry.
2. Extensive product portfolio: The company offers a wide range of software and services, including customer experience solutions, cloud-based platforms, and data analytics.
3. Global reach: Amdocs operates in multiple countries, allowing for a diversified revenue stream and access to various markets.
Weaknesses
1. Dependency on key clients: Amdocs relies heavily on a few major clients for a significant portion of its revenue, which poses a risk in case of client loss or downturn in their business.
2. Prone to external market factors: The company's performance can be affected by changes in government regulations, economic conditions, and technological advancements.
3. Limited diversification: Although Amdocs has expanded its product offerings, the majority of its revenue still comes from the telecommunications sector, making it vulnerable to industry-specific challenges.
Opportunities
1. Growing demand for digital transformation: Amdocs can capitalize on the increasing need for companies to adopt digital technologies and enhance their customer experience.
2. Expansion into new industries: The company can explore opportunities in sectors beyond telecommunications, such as financial services and healthcare, to diversify its revenue sources.
3. Potential for strategic partnerships: Collaborating with other technology companies or industry leaders can enable Amdocs to access new markets, expand its offerings, and enhance its competitive advantage.
Threats
1. Intense competition: Amdocs faces fierce competition from other software providers and service vendors in the telecommunications industry, leading to pricing pressures and potential loss of market share.
2. Rapid technological advancements: The need to constantly upgrade and adapt its solutions to keep pace with emerging technologies is a challenge that Amdocs must address to remain competitive.
3. Data security and privacy concerns: As the company deals with sensitive customer data, any breach or mishandling of information can damage its reputation and result in legal implications.
Amdocs Segments
Amdocs Revenue by Segment
3 Years
Max
Details
Amdocs Revenue by Region
3 Years
Max
Details
Amdocs Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Amdocs historical P/E ratio, EBIT multiple, and P/S ratio
Amdocs annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Amdocs shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Amdocs Dividend History
14 years of dividend payments · 13 consecutive increases
Amdocs dividend history and estimates
Max
Details
Amdocs dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Amdocs forecasts and price targets in March 2026
| Δ MOM Price Target | null % |
| Buy | 83.33 % (10) |
| Hold | 16.67 % (2) |
| Sell | null % (0) |
| 12M Price Target | 100.47 |
| Last Price | 68.65 |
| Currency | USD |
| 12M Return Potential | 46.35 % |
| LTM Return | 0 % |
Amdocs Earnings Estimates
Amdocs Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 2/3/2026 | 1.78USD | 1.17 BUSD | 2026 Q1 |
| 2/2/2026 | 1.78USD | 1.17 BUSD | 2026 Q1 |
| 11/12/2024 | 1.72USD | 1.28 BUSD | 2024 Q4 |
| 5/8/2024 | 1.62USD | 1.26 BUSD | 2024 Q2 |
| 1/29/2024 | 1.58USD | 1.26 BUSD | 2024 Q1 |
| 8/1/2023 | 1.52USD | 1.25 BUSD | 2023 Q3 |
| 5/9/2023 | 1.47USD | 1.23 BUSD | 2023 Q2 |
| 1/30/2023 | 1.33USD | 1.19 BUSD | 2023 Q1 |
| 11/8/2022 | 1.3USD | 1.18 BUSD | 2022 Q4 |
| 8/3/2022 | 1.28USD | 1.18 BUSD | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Amdocs stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Amdocs shareholders
| % | Name |
|---|---|
12.66293% | |
5.97387% | |
5.28460% | |
4.24095% | |
3.09269% | |
2.83718% | |
2.79006% | |
2.78265% | |
2.12362% | |
2.06610% |
Amdocs Executives and Management Board
Mr. Adrian Gardner
(62)Independent Director
Mr. Eliahu Gelman
(66)Chairman of the Board · since 2002
Mr. Shuky Sheffer
(64)President, Chief Executive Officer, Director · since 2013
Ms. Tamar Rapaport-Dagim
(53)Chief Financial Officer, Chief Operating Officer
Mr. Rajat Raheja
(54)Division President of Amdocs Development Centre India LLP
Amdocs Research
SoonDeep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.
Research reports are coming soon
We're building institutional-grade equity research for Amdocs and thousands of other companies.
Most common questions regarding Amdocs
Amdocs Ltd is a renowned multinational technology and services company specializing in software and solutions for the telecommunications industry. Their business model revolves around providing comprehensive customer experience solutions, enabling telecom service providers to streamline operations, enhance efficiency, and boost customer satisfaction. Amdocs offers a wide range of products and services, including customer relationship management, revenue management, and digital solutions, tailored to address the unique needs of telecom operators worldwide. With a strong focus on innovation and technology, Amdocs continues to grow as a leader in the telecom industry, delivering cutting-edge solutions and driving digital transformation for their clients.
Amdocs stock
Amdocs Peer Group
Amdocs Ticker
Amdocs FIGI
All fundamentals about Amdocs
Our stock analysis for Amdocs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amdocs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.